CYP2C19 Polymorphisms and Smoking Status Affects Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel
Cardiovascular Prevention and Pharmacotherapy · 2019
DOI: 10.36011/cpp.2019.1.e8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Prevention and Pharmacotherapy, 2019. Verfasst von Sang Won Han und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Han, S. W., Kim, Y., Seo, W., Yu, S., Nam, H. S., Yoon, S. S., Kim, S. H., Lee, J. Y., Lee, J. H., Hwang, Y., Lee, J., Lee, K., & Lee, K. (2019). CYP2C19 Polymorphisms and Smoking Status Affects Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel. Cardiovascular Prevention and Pharmacotherapy. https://doi.org/10.36011/cpp.2019.1.e8
Vancouver
Han SW, Kim Y, Seo W, Yu S, Nam HS, Yoon SS, et al. CYP2C19 Polymorphisms and Smoking Status Affects Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel. Cardiovascular Prevention and Pharmacotherapy. 2019. doi:10.36011/cpp.2019.1.e8
BibTeX
@article{Han2019,
author = {Han, Sang Won and Kim, Yong-Jae and Seo, Woo-Keun and Yu, Sungwook and Nam, Hyo Suk and Yoon, Sung Sang and Kim, Seo Hyun and Lee, Jong Yun and Lee, Jun Hong and Hwang, Yang-Ha and Lee, Jun and Lee, Kyung-A and Lee, Kyung-Yul},
title = {CYP2C19 Polymorphisms and Smoking Status Affects Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel},
journal = {Cardiovascular Prevention and Pharmacotherapy},
year = {2019},
doi = {10.36011/cpp.2019.1.e8}
}
EUVIMED